The National lnstitutes of Health National Heart, Lung and Blood Institute (NIH/NHLBI) - University of Maryland Fellowship Program is an Accreditation Council for Graduate Medical Education (ACGME) accredited 3-year combined Fellowship in Pulmonary and Critical Care Medicine, under the institutional sponsorship of the University of Maryland.
This joint fellowship program between the University of Maryland Medical Center and the NIH/NHLBI is designed to provide broad training in both clinical pulmonary and critical care medicine and in research. The program is open to all physicians who are board-certified or -eligible in internal medicine and who have strong interests in research. This usually requires that the applicant is either currently enrolled or will have completed a three-year residency in an approved internal medicine training program within the United States. This fellowship leads to board eligibility in Pulmonary and Critical Care Medicine and is designed to prepare fellows for a career in academic clinical investigation and clinical care.
The first 18 months of the fellowship are purely clinical, based at the University of Maryland Medical Center (UMMC) and the Baltimore VA Medical Center, with an elective in pulmonary consultation at the NIH Clinical Center in Bethesda, the world's largest clinical research complex. The last 18 months (with an option for a 4th year) are based at the NIH and are dedicated to research training. Additional information about the University of Maryland clinical components of this Pulmonary and Critical Care Medicine Fellowship are available at the UMMC website.
Research Opportunities in the NHLBI
Kenneth Olivier, MD, MPH, directs the Laboratory of Chronic Airway Infection, which focuses on clinical, translational and epidemiological studies of bronchiectasis and nontuberculous mycobacterial infections
Stewart Levine, MD directs the Laboratory of Asthma and Lung Inflammation which focuses on development of new treatments for severe asthma based on novel protective roles of apolipoproteins.
Joel Moss, MD, PhD directs the Laboratory of Translational Research, which focuses on basic research on the regulation of protein trafficking and post-translational modifications of proteins. His clinical trial work focuses on the pathogenesis of cystic lung diseases, notably lymphangioleiomyomatosis (LAM). Other laboratories in the NHLBI or other Institutes and Centers on the NIH campus may also be available for fellow research training.
Candidates should apply through the Electronic Residency Application Service (ERAS) which is handled through the University of Maryland Division of Pulmonary and Critical Care Medicine and follows the annual ERAS/AAMC timeline. Applicants should choose the 'UMMC NIH/NHLBI Track' on the application.